IL-12 and IL-23 pathway inhibition in inflammatory bowel disease

B Verstockt, A Salas, BE Sands, C Abraham… - Nature Reviews …, 2023 - nature.com
Abstract Interleukin-12 (IL-12) and interleukin-23 (IL-23), which belong to the IL-12 family of
cytokines, have a key role in intestinal homeostasis and inflammation and are implicated in …

IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting

AR Moschen, H Tilg, T Raine - Nature Reviews Gastroenterology & …, 2019 - nature.com
Abstract IL-12 and IL-23 are closely related cytokines with important roles in the regulation of
tissue inflammation. Converging evidence from studies in mice, human observational …

Genetic and epigenetic fine mapping of causal autoimmune disease variants

KKH Farh, A Marson, J Zhu, M Kleinewietfeld… - Nature, 2015 - nature.com
Genome-wide association studies have identified loci underlying human diseases, but the
causal nucleotide changes and mechanisms remain largely unknown. Here we developed a …

IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases

MWL Teng, EP Bowman, JJ McElwee, MJ Smyth… - Nature medicine, 2015 - nature.com
Abstract The cytokine interleukin-12 (IL-12) was thought to have a central role in T cell–
mediated responses in inflammation for more than a decade after it was first identified …

Genetics of inflammatory bowel diseases

DPB McGovern, S Kugathasan, JH Cho - Gastroenterology, 2015 - Elsevier
In this review, we provide an update on genome-wide association studies (GWAS) in
inflammatory bowel disease (IBD). In addition, we summarize progress in defining the …

Interleukin-23 in the pathogenesis of inflammatory bowel disease and implications for therapeutic intervention

GW Sewell, A Kaser - Journal of Crohn's and Colitis, 2022 - academic.oup.com
Abstract The interleukin-23 [IL-23] cytokine, derived predominantly from macrophages and
dendritic cells in response to microbial stimulation, has emerged as a critical promoter of …

Expansion of IL-23 receptor bearing TNFR2+ T cells is associated with molecular resistance to anti-TNF therapy in Crohn's disease

H Schmitt, U Billmeier, W Dieterich, T Rath… - Gut, 2019 - gut.bmj.com
Objective Anti-tumour necrosis factor (TNF) antibodies are successfully used for treatment of
Crohn's disease. Nevertheless, approximately 40% of patients display failure to anti-TNF …

Pattern recognition receptor signaling and cytokine networks in microbial defenses and regulation of intestinal barriers: implications for inflammatory bowel disease

C Abraham, MT Abreu, JR Turner - Gastroenterology, 2022 - Elsevier
Inflammatory bowel disease is characterized by defects in epithelial function and
dysregulated inflammatory signaling by lamina propria mononuclear cells including …

Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL …

C Tillack, LM Ehmann, M Friedrich, RP Laubender… - Gut, 2014 - gut.bmj.com
Background We analysed incidence, predictors, histological features and specific treatment
options of anti-tumour necrosis factor α (TNF-α) antibody-induced psoriasiform skin lesions …

The multitasking organ: recent insights into skin immune function

P Di Meglio, GK Perera, FO Nestle - Immunity, 2011 - cell.com
The skin provides the first line defense of the human body against injury and infection. By
integrating recent findings in cutaneous immunology with fundamental concepts of skin …